8.71
price up icon2.11%   0.18
after-market 시간 외 거래: 8.75 0.04 +0.46%
loading
전일 마감가:
$8.53
열려 있는:
$8.55
하루 거래량:
5.15M
Relative Volume:
0.83
시가총액:
$1.41B
수익:
$1.08B
순이익/손실:
$422.82M
주가수익비율:
3.8202
EPS:
2.28
순현금흐름:
$-637.33M
1주 성능:
+9.15%
1개월 성능:
-8.51%
6개월 성능:
+10.11%
1년 성능:
-30.43%
1일 변동 폭
Value
$8.52
$8.82
1주일 범위
Value
$7.875
$8.82
52주 변동 폭
Value
$5.01
$15.22

노바백스 Stock (NVAX) Company Profile

Name
명칭
Novavax Inc
Name
전화
240-268-2000
Name
주소
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Name
직원
1,992
Name
트위터
@novavax
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
NVAX's Discussions on Twitter

NVAX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
NVAX
Novavax Inc
8.71 1.39B 1.08B 422.82M -637.33M 2.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
383.12 99.25B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
591.99 63.46B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.56 59.27B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
736.76 44.78B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
334.40 37.75B 3.81B -644.79M -669.77M -6.24

노바백스 Stock (NVAX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-08-28 재개 H.C. Wainwright Buy
2025-08-20 다운그레이드 BofA Securities Neutral → Underperform
2025-06-17 개시 Citigroup Sell
2025-02-28 개시 BTIG Research Buy
2024-07-30 다운그레이드 JP Morgan Neutral → Underweight
2024-05-10 업그레이드 BofA Securities Underperform → Neutral
2024-05-10 업그레이드 JP Morgan Underweight → Neutral
2023-08-09 업그레이드 B. Riley Securities Neutral → Buy
2023-04-20 다운그레이드 TD Cowen Outperform → Market Perform
2023-03-01 다운그레이드 B. Riley Securities Buy → Neutral
2023-01-09 재확인 B. Riley Securities Buy
2022-12-30 재확인 H.C. Wainwright Buy
2022-12-02 개시 Jefferies Hold
2022-09-22 다운그레이드 JP Morgan Neutral → Underweight
2022-05-20 개시 BofA Securities Underperform
2022-02-23 재확인 B. Riley Securities Buy
2022-02-22 재개 Jefferies Buy
2022-01-21 개시 Cowen Outperform
2021-05-12 다운그레이드 JP Morgan Overweight → Neutral
2020-12-14 개시 Jefferies Buy
2020-08-06 재확인 H.C. Wainwright Buy
2020-08-05 업그레이드 JP Morgan Neutral → Overweight
2020-08-05 다운그레이드 Ladenburg Thalmann Neutral → Sell
2020-07-16 재확인 H.C. Wainwright Buy
2020-07-08 다운그레이드 Ladenburg Thalmann Buy → Neutral
2020-06-29 재확인 B. Riley FBR Buy
2020-06-29 재확인 H.C. Wainwright Buy
2020-06-05 업그레이드 JP Morgan Underweight → Neutral
2020-05-28 재확인 B. Riley FBR Buy
2020-05-12 재확인 H.C. Wainwright Buy
2020-04-30 재확인 H.C. Wainwright Buy
2019-11-27 재개 B. Riley FBR Buy
2019-08-14 재확인 H.C. Wainwright Buy
2019-02-28 다운그레이드 Piper Jaffray Overweight → Underweight
2018-12-18 개시 Ladenburg Thalmann Buy
2018-12-11 개시 Oppenheimer Outperform
2018-11-26 업그레이드 Piper Jaffray Neutral → Overweight
2018-09-21 업그레이드 JP Morgan Underweight → Overweight
2018-03-29 업그레이드 Seaport Global Securities Neutral → Buy
모두보기

노바백스 주식(NVAX)의 최신 뉴스

pulisher
03:50 AM

Novavax, Inc. $NVAX Stock Position Lessened by Goldman Sachs Group Inc. - MarketBeat

03:50 AM
pulisher
02:08 AM

Novavax Falls on Report That FDA Wants New Covid Vaccine Trial - MSN

02:08 AM
pulisher
06:01 AM

Novavax (NASDAQ:NVAX) Shares Up 5.1%Still a Buy? - MarketBeat

06:01 AM
pulisher
12:54 PM

US Market Wrap: Can NTWOU generate free cash flow2025 Risk Factors & Real-Time Volume Spike Alerts - khodrobank.com

12:54 PM
pulisher
Sep 19, 2025

Buybacks Report: Will Novavax Inc stock go up in YEARJuly 2025 Gainers & Safe Entry Momentum Stock Tips - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

US vaccine advisers abandon broad recommendation for COVID shots - MarketScreener

Sep 19, 2025
pulisher
Sep 19, 2025

Dow Update: Can Novavax Inc deliver consistent EPS growth2025 Technical Patterns & Detailed Earnings Play Strategies - khodrobank.com

Sep 19, 2025
pulisher
Sep 18, 2025

Market Recap: Is Novavax Inc currently under institutional pressure2025 Technical Patterns & Daily Growth Stock Tips - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Market Rankings: Is Novavax Inc a defensive stockJuly 2025 Recap & Smart Investment Allocation Insights - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'Dynavax Technologies (NASDAQ:DVAX), GSK (NYSE:GSK) - Benzinga

Sep 18, 2025
pulisher
Sep 18, 2025

Weekly Recap: How correlated is Novavax Inc to the S P500Portfolio Performance Report & Intraday High Probability Alerts - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Volume Recap: Does Babcock & Wilcox Enterprises Inc. meet Warren Buffett’s criteriaJuly 2025 Institutional & Stepwise Trade Signal Guides - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Action: Is Novavax Inc a play on infrastructure spendingCEO Change & Weekly High Conviction Trade Ideas - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Novavax: Endlessly Frustrating, Endlessly FascinatingWarrants Rating Upgrade (NVAX) - Seeking Alpha

Sep 18, 2025
pulisher
Sep 18, 2025

November 21st Options Now Available For Novavax (NVAX) - Nasdaq

Sep 18, 2025
pulisher
Sep 17, 2025

Here's Why Novavax (NVAX) Fell More Than Broader Market - Yahoo Finance

Sep 17, 2025
pulisher
Sep 17, 2025

West Coast states issue own vaccine guidance citing “politicization of science” under Trump - Seeking Alpha

Sep 17, 2025
pulisher
Sep 17, 2025

Noteworthy Wednesday Option Activity: TGT, NVAX, DXCM - Nasdaq

Sep 17, 2025
pulisher
Sep 17, 2025

MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response - Zacks Investment Research

Sep 17, 2025
pulisher
Sep 17, 2025

Bayforest Capital Ltd Buys New Shares in Novavax, Inc. $NVAX - MarketBeat

Sep 17, 2025
pulisher
Sep 16, 2025

Novavax Inc. Stock Climbs 5.9%, Outperforms Peers - 富途牛牛

Sep 16, 2025
pulisher
Sep 16, 2025

Buybacks Report: Is Novavax Inc. exposed to currency risksJuly 2025 Volume & Free Expert Approved Momentum Trade Ideas - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Market Recap: Can Novavax Inc sustain its profitabilityJuly 2025 Sector Moves & Long-Term Safe Investment Ideas - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Highlights: Is Novavax Inc stock technically oversoldQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Selloffs: Is Novavax Inc a play on infrastructure spendingQuarterly Portfolio Review & Expert Curated Trade Ideas - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Profit Review: What is Novavax Incs TAM Total Addressable MarketJuly 2025 Summary & Weekly Top Gainers Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Is Novavax at Risk After White House Considers COVID Shot Restrictions? - Yahoo Finance

Sep 15, 2025
pulisher
Sep 12, 2025

Market Voices: Kenvue vs. RFK Jr., COVID shot safety, Lendbuzz IPO - Seeking Alpha

Sep 12, 2025
pulisher
Sep 11, 2025

Northern Trust Corp Sells 48,282 Shares of Novavax, Inc. $NVAX - MarketBeat

Sep 11, 2025
pulisher
Sep 11, 2025

Park West Asset Management LLC Invests $16.21 Million in Novavax, Inc. $NVAX - MarketBeat

Sep 11, 2025
pulisher
Sep 11, 2025

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - sharewise.com

Sep 11, 2025
pulisher
Sep 10, 2025

Novavax gets Japan nod for its COVID-19 vaccine, triggers Takeda payment - MSN

Sep 10, 2025
pulisher
Sep 10, 2025

FDA Moves To Publicize Data On Pregnant Women's Covid Vaccine Side Effects - Benzinga

Sep 10, 2025
pulisher
Sep 09, 2025

Market Trends: Is Novavax Inc. currently under institutional pressureQuarterly Risk Review & Safe Entry Point Identification - Lancaster City Council

Sep 09, 2025
pulisher
Sep 08, 2025

What is Novavax Inc.’s TAM (Total Addressable Market)Market Rally & AI Optimized Trading Strategy Guides - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

Will Novavax Inc. benefit from sector rotationMarket Sentiment Report & Daily Oversold Stock Bounce Ideas - beatles.ru

Sep 08, 2025

노바백스 (NVAX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

노바백스 주식 (NVAX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Alton Gregg H
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
28,805
King Rachel K.
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
25,190
Rodgers Richard J
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
24,690
MOTT DAVID M
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
60,890
DOUGLAS RICHARD
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
54,340
$36.24
price up icon 1.43%
$86.53
price up icon 0.62%
$28.28
price up icon 0.86%
$96.22
price down icon 0.09%
$144.76
price down icon 0.75%
biotechnology ONC
$334.40
price down icon 2.48%
자본화:     |  볼륨(24시간):